2024
Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases
Ghabili K, Windham-Herman A, Konstantinidis M, Murali N, Borde T, Adam L, Laage-Gaupp F, Lin M, Chapiro J, Georgiades C, Nezami N. Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases. Annals Of Hepatology 2024, 29: 101529. PMID: 39033928, PMCID: PMC11558520, DOI: 10.1016/j.aohep.2024.101529.Peer-Reviewed Original ResearchConventional transarterial chemoembolizationLiver metastasesNeuroendocrine tumorsColorectal carcinomaTransarterial chemoembolizationOverall survivalLung cancerAssociated with improved patient survivalManagement of liver metastasesMetastatic liver lesionsSingle-institution analysisNonresponding patientsSurvival outcomesPatient survivalResponse assessmentTarget lesionsMetastasisLiver lesionsPatientsResponse rateChemoembolizationSurvivalLiverLesionsCancer
2020
Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer
Stark S, Wang C, Savic LJ, Letzen B, Schobert I, Miszczuk M, Murali N, Oestmann P, Gebauer B, Lin M, Duncan J, Schlachter T, Chapiro J. Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer. Scientific Reports 2020, 10: 18026. PMID: 33093524, PMCID: PMC7582153, DOI: 10.1038/s41598-020-75120-7.Peer-Reviewed Original ResearchConceptsConventional transarterial chemoembolizationLipiodol depositionTransarterial chemoembolizationLiver cancerPeripheral depositionLipiodol depositsTherapeutic efficacyNecrotic tumor areasBaseline MRITherapy optionsTumor responseTreatment responseTumor volumeLiver lesionsLipiodolH postTumor areaH-CTHounsfield unitsBiomarkersChemoembolizationHigh rateTumorsCancerImproved response
2018
4:21 PM Abstract No. 331 Quantitative analysis of Lipiodol washout rates in intrahepatic cholangiocarcinoma and hepatic metastasis from neuroendocrine tumors and colorectal cancer after chemoembolization
Nezami N, Van Breugel M, Miszczuk M, Rexha I, Windham-Herman A, Savic L, Murali N, Lin M, Chapiro J, Geschwin J. 4:21 PM Abstract No. 331 Quantitative analysis of Lipiodol washout rates in intrahepatic cholangiocarcinoma and hepatic metastasis from neuroendocrine tumors and colorectal cancer after chemoembolization. Journal Of Vascular And Interventional Radiology 2018, 29: s142. DOI: 10.1016/j.jvir.2018.01.367.Peer-Reviewed Original Research
2015
How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer
Tacher V, Radaelli A, Lin M, Geschwind JF. How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer. Radiology 2015, 274: 320-334. PMID: 25625741, PMCID: PMC4314294, DOI: 10.1148/radiol.14131925.Peer-Reviewed Original ResearchConceptsTransarterial chemoembolizationLiver cancerContrast material injection protocolsTime of procedureTwo-dimensional angiographyClinical evidenceTreatment successLiver tumorsMicrocatheter placementInterventional radiologyInterventional proceduresCBCT technologyDiagnostic imagingCone beamInjection protocolCBCT techniqueCBCT imagingCone-beam CTTumorsRoutine utilizationChemoembolizationCBCT imagesC-armCancerCBCT4:33 PM, Abstract No. 54 FEATURED ABSTRACT, Hong Kong liver cancer staging outperforms Barcelona clinic liver cancer staging as a prognostic classification system in patients treated with intra-arterial therapy: a North American study
Sohn J, Duran R, Lee H, Sahu S, Schernthaner R, Zhao L, Lin M, Fleckenstein F, Zhao Y, Geschwind J. 4:33 PM, Abstract No. 54 FEATURED ABSTRACT, Hong Kong liver cancer staging outperforms Barcelona clinic liver cancer staging as a prognostic classification system in patients treated with intra-arterial therapy: a North American study. Journal Of Vascular And Interventional Radiology 2015, 26: s30. DOI: 10.1016/j.jvir.2014.12.086.Peer-Reviewed Original Research